[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Progress Toward an All Oral Treatment for Newly Diagnosed Older Adults with AML with Gabriel Mannis, MD

Progress Toward an All Oral Treatment for Newly Diagnosed Older Adults with AML with Gabriel Mannis, MD image

Progress Toward an All Oral Treatment for Newly Diagnosed Older Adults with AML with Gabriel Mannis, MD

Podcast
event Sep 13, 2021 / 03:00PM CDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

In this HealthTree Radio for AML show, Dr. Gabriel Mannis talks about treatment options for older adults with AML. He reviews his open clinical trial looking at what could be the first all-oral treatment for newly diagnosed older patients. The combination of venetoclax and decitabine with cedazuridine (ASTX727 or Inqovi) would provide older adults with AML and those who cannot tolerate standard intensive chemotherapy a much-needed alternative treatment option.

To listen to the recording or read the transcript of this past radio show,

click here

Schedule & Agenda

Event panelist
03:00 PM
Welcome
Welcome, announcements and introduction
Event panelist
03:05 PM
Interview
Dr. Mannis answers questions about his open clinical trial: Pharmacokinetics, Safety, and Efficacy of Decitabine/Cedazuridine (ASTX727) in Combination With Venetoclax in Acute Myeloid Leukemia (AML)
Event panelist
03:50 PM
Q&A
Audience is able to call in to the radio show (515) 602-9728 to ask Dr. Mannis questions.

Speakers & Moderators

The panelist Gabriel Mannis, MD
Gabriel Mannis, MD
Palo Alto, CA

Dr. Mannis is Assistant Professor of Medicine in the Division of Hematology at Stanford University School of Medicine, and Medical Director of Stanford’s Inpatient Leukemia Service. He specializes in the treatment of acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), and other hematologic malignancies. As a clinical scientist, Dr. Mannis divides his time between caring for patients, teaching trainees, and researching novel therapies for AML and MDS.

Read Bio
The panelist Katie Braswell
Katie Braswell
Dallas, Texas

Katie joined the HealthTree Foundation as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors, and travel to new places.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Acute Myeloid Leukemia Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.